Pharmawire Quotes Partner Richard E. Donovan on ISC Holding's Contract Dispute with Nobel Biocare
January 4, 2010
Partner Richard E. Donovan was quoted in a Pharmawire article, “Nobel Potentially Owes ISC USD 272M for AMF Agreement; Attorneys Say Former Treasurer Bound Company to Agreement.” The article discussed the dispute over an asset management and facilitation (AMF) agreement between ISC Holding AG and Nobel Biocare Investments N.V. Nobel claims that its former corporate treasurer did not have the authority to sign the AMF agreement which appointed ISC to act as Nobel’s asset and investment manager for certain assets. Nobel Biocare is a major maker of dental implants. ISC is an investment company based in Switzerland.